CD8A and cancer: For cancers that have shown a good response to immune checkpoint inhibitors (SKCM, KIRC, BLCA, LUAD, HNSC), a positive correlation between CD8+ T cells and NK cells, was observed with the strongest correlation detected in SKCM and LUAD (Figure 2B).